Skip to main content
Medical information Clinical review pending

Genetic Testing

CYP3A5 Gene Hypertension Salt-Sensitive Essential Susceptibility to Genetic Test

Understand your genetic predisposition to salt-sensitive hypertension with the CYP3A5 Gene Hypertension test. This genetic DNA test uses Next-Generation Sequencing (NGS) to analyze your CYP3A5 gene, providing insights for personalized health management.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample or extracted DNA.
Results
Confirm with the laboratory before booking.
Preparation
Confirm with the laboratory before booking.
Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the CYP3A5 Gene Hypertension Salt-Sensitive Essential Susceptibility to Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Family history of hypertension or vascular diseases
  • ✓Individuals experiencing symptoms potentially related to hypertension
  • ✓Patients seeking to understand genetic risk factors for hypertension
  • ✓Personalized health management planning
  • ✓Guidance for lifestyle and dietary modifications
  • ✓Informed discussions with healthcare providers
02

In plain language

What this test helps you understand

This test helps identify individuals with a genetic predisposition to salt-sensitive essential hypertension, aiding in risk assessment and personalized management strategies.
The CYP3A5 Gene Hypertension Salt-Sensitive Essential Susceptibility test is a genetic analysis that helps understand your potential risk for developing hypertension, specifically the salt-sensitive type. This test examines variations within the CYP3A5 gene, which is involved in how your body processes certain medications and influences cardiovascular health. Using advanced Next-Generation Sequencing (NGS) technology, we can identify genetic markers associated with increased susceptibility to hypertension. Understanding this genetic predisposition can empower you and your doctor to make informed decisions about lifestyle, diet, and potential preventative measures. A genetic counseling session is recommended to help interpret the results and discuss their implications for your health.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationConfirm with the laboratory before booking.
SampleBlood sample or extracted DNA.
MethodologyNext-Generation Sequencing (NGS) analysis of the CYP3A5 gene.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test identifies genetic susceptibility but does not guarantee the development of hypertension. Environmental and lifestyle factors also play a significant role. Results should be interpreted by a qualified healthcare professional.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

The CYP3A5 gene provides instructions for making an enzyme involved in breaking down certain substances in the body, including some medications and compounds related to blood pressure regulation.
Salt-sensitive hypertension is a type of high blood pressure that is more affected by salt intake than other types. Genetic factors can influence this sensitivity.
Individuals with a family history of hypertension, those experiencing related symptoms, or anyone advised by their doctor to understand their genetic risks may benefit from this test.
A genetic counseling session is recommended to help you understand your results and discuss their implications with a healthcare professional.
No, this test assesses genetic susceptibility to hypertension. A diagnosis requires a clinical evaluation by a healthcare provider.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp